Back to search

Article

Combating the SARS-CoV-2 Omicron variant with non-Omicron neutralizing antibodies

2022-01-31

Abstract excerpt

The highly mutated and transmissible Omicron variant has provoked serious concerns over its decreased sensitivity to the current coronavirus disease 2019 (COVID-19) vaccines and evasion from most anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) neutralizing antibodies (NAbs). In this study, we explored the possibility of combatting the Omicron variant by constructing bispecific antibodies based on...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
5e6f6175-c01e-536c-9eb5-492bf75e937e
DOI
10.1101/2022.01.30.478305
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Combating the SARS-CoV-2 Omicron variant with non-Omicron neutralizing antibodiesDOI 10.1101/2022.01.30.478305
Select a neighboring publication to make it the new centre.